Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy-Reference-Cited by-同舟云学术

Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy

Published:2021-03-26 Issue:28 Volume:17 Page:2006000
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Qin Lin¹²^ORCID,Zhang Huilin¹^ORCID,Zhou Yang¹,Umeshappa Channakeshava Sokke³,Gao Huile¹^ORCID

Affiliation:

1. Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry and Sichuan Province Sichuan Engineering Laboratory for Plant‐Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology West China School of Pharmacy Sichuan University Chengdu 610041 China

2. Chongqing Vocational College of Transportation Chongqing 400715 China

3. Department of Microbiology Immunology and Infectious Diseases Snyder Institute for Chronic Diseases Cumming School of Medicine University of Calgary Calgary Alberta T2N 4N1 Canada

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202006000

Reference249 articles.

1. The future of immune checkpoint therapy

2. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

3. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies